Search Results 2361-2370 of 14788 for anti-TNF drugs

  1. Sulfur Hexafluoride Lipid Type A Microspheres (Injection Route, Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Teriparatide (Subcutaneous Route) Precautions - Mayo Clinic

    This medicine may increase your risk of having osteosarcoma (bone cancer). This is more likely to occur if you have a history of radiation treatment ...

  3. Effect of T6 Dermatome Electrical Stimulation on Gastroduodenal Motility in Healthy Volunteers - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Exceptions are birth control pill, estrogen replacement therapy, ...

  4. Mayo Clinic Cardiology Referral Program

    Similar to Mayo Clinic's Recognized Referral Facilitators, participants in the program provide to patients seeking treatment at Mayo Clinic previsit assistance ...

  5. Tafenoquine (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. A Study to Collect and Correlate the Data from Multiple Risk Assessments for Heart Toxicity in Patients Receiving Chemotherapy for Breast Cancer - Mayo Clinic

    Participation eligibility · Newly diagnosed with HER-2 positive breast cancer · Seen at Mayo Clinic Rochester · Is planning to undergo anti-HER2 therapy with or ...

  7. Back Pain Clinical Trials - Mayo Clinic Research

    We hypothesize that a device which measures compliance to physical therapy regimens in patients with low back pain will increase patient participation. Spinal ...

  8. Publications - Sabrina Sahni, M.D. - Mayo Clinic

    David PS, Sobel T, Sahni S, Mehta J, Kling JM. Menopausal Hormone Therapy in Older Women: Examining the Current Balance of Evidence. Drugs Aging. 2023 Aug ...

  9. Targeted Drug Can ‘Diminish the Suffering’ of Myelofibrosis - Mayo Clinic News Network

    CHICAGO — Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic ...

  10. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... anti-CD20 antibodies, BCL-2 inhibitors, and PI3k inhibitors.